NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Organization and Basis of Presentation
The accompanying consolidated audited financial statements of BOTS, Inc., (the “Company”, “we”, “our”), have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”).
Basis of Presentation and Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries and have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). All significant intercompany accounts and transactions have been eliminated.
Description of Business
We were incorporated in the State of Nevada on December 30, 2010 originally under the name Lifetech Industries, Inc. All agreements related to the Lifetech business were terminated and closed as of April 30, 2014. Effective August 2, 2013, the name was changed from "Lifetech Industries, Inc." to "BOTS, Inc." The Company’s common stock is traded under the symbol “BOTS.” The Company is based in Jacksonville, Florida.
Originally, we were formed to open and operate a full-service day spa in Montrose, California. In October 2013 we repositioned ourselves as a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes; and, (2) the adoption of electronic vaporizing cigarettes (commonly known as “eCigs”).
The Company initially earned revenue through wholesale and retail sales of electronic cigarettes, vaporizers, and accessories in the United States. It offered electronic cigarettes and related products through its online store at www.BOTS.BZ, as well as through the company’s wholesale, distributor, and retail programs. We expanded operations to include the VitaCig brand in 2014.
From 2015 through 2020 the Company was involved in multiple cannabis business entities. We have elected to discontinue all operations in the cannabis markets and focus on robotics.
During this fiscal year, we operated multiple websites (which are not incorporated as part of this Form 10K report). The Company’s primary website is www.BOTS.BZ.
Subsidiaries of the Company
The following subsidiaries are incorporated in the financials for the year ending April 30, 2020 but have been discontinued as operational elements of BOTS, Inc.
VitaCig, Inc.
On May 26, 2016 we incorporated VitaCig, Inc., (“VitaCig”) in the state of Florida. VitaCig headquarters our global e-cig operations. VitaCig, Inc., is a wholly owned subsidiary of the Company. VitaCig ceased operations under BOTS on April 30, 2020. On May 1, 2020 the assets of VitaCig was transferred to Paul Rosenberg as settlement of debt.
MCIG Internet Sales, Inc.
On June 1, 2016, the Company incorporated MCIG Internet Sales, Inc., (“MCIG Internet”) in the state of Florida in order to operate our CBD business and to consolidate all wholesale and online retail sales from various websites. MCIG Internet is a wholly owned subsidiary of the Company. MCIG Internet Sales, Inc., ceased operations under BOTS on April 30, 2020.
CAL Acres Foundation (FKA Newco2, Inc)
Cal Foundation was created on January 19, 2019 as a California not-for-profit company. Cal Foundation maintains three cannabis licenses in the State of California.
CAAcres, Inc.
CAAcres, Inc., (“CAAcres”) was incorporated on May 10, 2019 under the laws of the state of California. CAAcres was created to participate in the Joint Venture with Cal Foundation for the cultivation, manufacturing, and distribution of cannabis products within the state of California. CAAcres is an agriculture venture for the cultivation, manufacturing and distribution of cannabis products. We are currently assessing the requirements for the build out of the land acquired in California City, California for this project.
Vapolution, Inc.
On January 23, 2014, the Company entered into a Stock Purchase Agreement acquiring 100% ownership in Vapolution, Inc., which manufactures and retails home-use vaporizers. Effective January 17, 2017 we began consolidating Vapolution with the Company’s financial reports. Vapolution ceased operations during fiscal year 2020. Vapolution, Inc., was wholly owned by BOTS, Inc.
Cannabiz Supply, LLC
On June 30, 2019 the company elected to exercise its option to acquired Cannabiz Supply with an effective date of May 1, 2019. The purchase price was $3,457,796.
Note 2. Summary of Significant Accounting Policies
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The most significant estimates include: revenue recognition; sales returns and other allowances; allowance for doubtful accounts; valuation of inventory; valuation and recoverability of long-lived assets; property and equipment; contingencies; and income taxes.
On a regular basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.
Revenue Recognition Policies
We intend to earn revenue from the subscription, non-software related hosted services, term-based and perpetual licensing of software products, associated software maintenance and support plans, consulting services, training, and technical support.
On February 1, 2019, we adopted Topic 606, using the modified retrospective transition method applied to those contracts which were not completed as of February 1, 2019. Results for reporting periods beginning after February 1, 2019 are presented under Topic 606, while prior period amounts have not been adjusted and continue to be reported in accordance with our historic accounting. The impact of adopting the new revenue standard was not material to our financial statements and there was no adjustment to beginning retained earnings on February 1, 2019.
Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.
We determine revenue recognition through the following steps:
|
·
|
identification of the contract, or contracts, with a customer;
|
|
·
|
identification of the performance obligations in the contract;
|
|
·
|
determination of the transaction price;
|
|
·
|
allocation of the transaction price to the performance obligations in the contract; and
|
|
·
|
recognition of revenue when, or as, we satisfy a performance obligation.
|
Concentration of Credit Risk and Significant Customers
Financial instruments which potentially subject the Company to a concentration of credit risk consist principally of temporary cash investments and accounts receivable. The Company places its temporary cash investments with financial institutions insured by the FDIC.
Concentrations of credit risk with respect to trade receivables are limited due to the diverse group of customers to whom the Company sells. The Company establishes an allowance for doubtful accounts when events and circumstances regarding the collectability of its receivables warrant based upon factors such as the credit risk of specific customers, historical trends, other information and past bad debt history. The outstanding balances are stated net of an allowance for doubtful accounts.
For the years ended April 30, 2020 and April 30, 2019, the Company has no customers who impact the Company’s revenues or receivables more than 5%.
Stock-Based Compensation
The Company accounts for share-based awards issued to employees in accordance with FASB ASC 718, Compensation – Stock Compensation. Accordingly, employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period. Additionally, share-based awards to non-employees are expensed over the period in which the related services are rendered at their fair value. The Company applies ASC 505-50, Equity Based Payments to Non-Employees, with respect to options and warrants issued to non-employees.
Deferred Revenue
Payments received by the Company in advance are recorded as deferred revenue until the merchandise has shipped to the customer.
Cost of Goods Sold
The Company recognizes the direct cost of purchasing product for sale, including freight-in and packaging, as cost of goods sold in the accompanying statement of operations.
Cost of Revenue
Cost of revenue includes: manufacturing and distribution costs for products sold and programs licensed; operating costs related to product support service centers and product distribution centers; costs incurred to include software on PCs sold by OEMs, to drive traffic to our websites and products, and to acquire online advertising space; costs incurred to support and maintain Internet-based products and services, including datacenter costs and royalties; warranty costs; inventory valuation adjustments; costs associated with the delivery of consulting services; and the amortization of capitalized software development costs. Capitalized software development costs are amortized over the estimated lives of the products.
Cash and Cash Equivalents
The Company includes in cash and cash equivalents all short-term, highly liquid investments that mature within three months of the date of purchase. Cash equivalents consist principally of investments in interest-bearing demand deposit accounts and liquidity funds with financial institutions and are stated at cost, which approximates fair value. For cash management purposes, the company concentrates its cash holdings in multiple FDIC insured state and federal banking institutions. The Company had no cash equivalents at April 30, 2020 or 2019.
Inventory
In accordance with ASU 2015-11 – Inventory (Topic 330) – Simplifying the Measurement of Inventory, the Company’s inventory consists of finished product, BOTS products valued at the lower of cost or market valuation under the first-in, first-out method of costing.
As of April 30, 2020, the Company had no allowance for obsolescence.
Property, Plant, and Equipment
Property, plant and equipment (“PPE”) are stated at cost less accumulated depreciation and amortization. Expenditures for maintenance and repairs are charged to expense as incurred. Additions, improvements and major replacements that extend the life of the asset are capitalized.
Depreciation and amortization is recorded using the straight-line method over the estimated useful lives of depreciable assets, which are generally three to five years.
The Company classifies its software under the Financial Accounting Standards Advisory Board (FASAB) Statement of Federal Financial Accounting Standards (SFFAS) No. 10, Accounting for Internal Use Software, and the Governmental Accounting Standards Board (GASB) Statement No. 42, Accounting of Costs of Computer Software Developed or Obtained for Internal Use. When software is used in providing goods and services it is classified as PPE. The Company considers its 420 Cloud software as a major part of the Company’s operations that is intended to provide profits.
Accounts Receivable
The Company’s accounts receivables are primarily through its construction and media and technologies segments. As the retail division is either paid through credit card processing and prepaid wholesale purchases, the Company projects insignificant amounts of outstanding accounts receivable for its retail division. The Company recognizes receipt of payment at the time the funds are deposited with the merchant services account of the Company. When the merchant services vendor determines to maintain a reserve for potential refunds and chargebacks, the Company reviews the reserve, to i) determine if the reserve is probably uncollectible, and ii) if a loss is probable, a reasonable estimate of the amount of the loss. We then allocate a portion or all of the reserve for bad debt, in accordance with FASB ASC 450-20-25-2. Once the vendor releases the funds, the bad debt reserve is appropriately reversed. The Company recognized $1,395,605 and $0 as an uncollectable reserve for the periods ending April 30, 2020 and April 30, 2019, respectively.
Advertising Costs and Expense
The advertising costs are expensed as incurred. During the years ended April 30, 2020 and 2019, the advertising costs were $30,197 and $73,091, respectively.
Foreign Currency Translation
The Company’s functional currency and its reporting currency is the United States Dollar.
Intangible Assets
The Company’s intangible assets consist of certain website development costs that is amortized over their useful life in accordance with the guidelines of ASC 350-30 General Intangible Other than Goodwill and ASC 350-50 Website Development Costs. In addition to these finite intangible assets, the Company accounts for its infinite intangible assets without depreciation and/or amortization. These assets are reviewed annually by an independent review to determine if an impairment should be recognized. The Company determined impairments were warranted for the Company’s intangible assets (see Note 9 for further information).
Financial Instruments
The carrying amounts reflected in the balance sheets for cash, accounts receivable, accounts payable and accrued expenses approximate the respective fair values due to the short maturities of these items. The Company does not hold any investments that are available-for-sale.
As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
The three levels of the fair value hierarchy are described below:
Level 1—Valuations based on quoted prices for identical assets and liabilities in active markets.
Level 2—Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
Level 3—Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.
Income Taxes
Income taxes are accounted for under the assets and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled.
Basic and Diluted Net Loss Per Share
The Company follows ASC Topic 260 – Earnings Per Share, and FASB 2015-06, Earnings Per Share to account for earnings per share. Basic earnings per share (“EPS”) calculations are determined by dividing net loss by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.
Basic net earnings (loss) per common share are computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. Dilutive common stock equivalent shares consist of Series A convertible preferred stock, convertible debentures, stock options and warrant common stock equivalent shares.
Concentration of Credit Risk
Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and trade receivables. Concentrations of credit risk with respect to trade receivables are limited due to the clients that comprise our customer base and their dispersion across different business and geographic areas. We estimate and maintain an allowance for potentially uncollectible accounts and such estimates have historically been within management's expectations.
We rely almost exclusively on one Chinese factory as our principle supplier for our e-cig products. Therefore, our ability to maintain operations is dependent on this third-party manufacturer.
Our cash balances are maintained in accounts held by major banks and financial institutions located in the United States. The Company may occasionally maintain amounts on deposit with a financial institution that are in excess of the federally insured limit of $250,000. The risk is managed by maintaining all deposits in high quality financial institutions. The Company had $0 in excess of federally insured limits at April 30, 2020 and 2019.
Impairment of Long-lived Assets
The Company accounts for long-lived assets in accordance with the provisions of FASB Topic 360, “Accounting for the Impairment of Long-Lived Assets”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized when the estimated future cash flows from the use of the asset are less than the carrying amount of that asset.
In accordance with Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, ASU 2011-08, Intangible-Goodwill and Other (Topic 350)” Testing Goodwill for Impairment, and ASU 2012-02 Intangibles-Goodwill and Other (Topic 350) Testing Indefinite-Lived Intangible Assets for Impairment our intangible assets are evaluated for potential impairment annually, generally during the fourth quarter, by comparing the fair value of a reporting unit to its carrying value. If the carrying value exceeds the fair value, impairment is measured by comparing the derived fair value of to its carrying value, and any impairment determined would be recorded in the current period. The Company recognized no impairment on its intangible assets for the periods ending April 30, 2019 and April 30, 2017.
Cost-Basis Investments
The Company’s non-marketable equity investment in Omni Health, Inc., and Stony Hill Corp is recorded using the cost-basis method of accounting and is classified within other long-term assets on the accompanying balance sheet as permitted by FASB ASC 325, “Cost Method Investments”. The Company elected to purchase CBJ Distributing under its Option Agreement subsequent to this reporting period, as such we maintain the cost-basis for this option. During 2020 we impaired a total of $386,031 (see Note 7). We impaired $152,023 of our investment in Omni Health, Inc., $24,000 of our Stony Hill stock, $160,008 of our investment in the acquisition of Agri-Contractors, and $50,000 in our OBITX investment.
Equity-Basis Investments
The Company accounted for its ownership of VitaCig, Inc., (Nevada) as an equity-basis investment. As of April 30, 2020, and April 30, 2019, there is no net book value of the ownership of VitaCig, as the pro-rata value after the Spin-off and the impairment of the investment in VitaCig.
On June 22, 2016, the Company reduced its ownership of VitaCig, Inc., to 57,500,000 through a Separation and Transfer Agreement where the Company acquired the business operations of VitaCig in exchange for selling back to the treasury of VitaCig, Inc., (Nevada) 172,500,000.
Warranties
Warranty reserves include management’s best estimate of the projected costs to repair or to replace any items under warranty, based on actual warranty experience as it becomes available and other known factors that may impact the Company’s evaluation of historical data. Management reviews BOTS’s reserves at least quarterly to ensure that its accruals are adequate in meeting expected future warranty obligations, and the Company will adjust its estimates as needed. Initial warranty data can be limited early in the launch of a product and accordingly, the adjustments that are recorded may be material. As a result, the products that can be returned as a warranty replacement are extremely limited. As a result, due to the Company’s warranty policy, the Company did not have any significant warranty expenses to report for the year ended April 30, 2020. Based on these actual expenses, the warranty reserve, as estimated by management as of April 30, 2020 and April 30, 2019 were at $0. Any adjustments to warranty reserves are to be recorded in cost of sales.
It is likely that as we start selling higher priced products, that are not affected by federal shipping laws and/or are not single use items, we will acquire additional information on the projected costs to service work under warranty and may need to make additional adjustments. Further, a small change in the Company’s warranty estimates may result in a material charge to the Company’s reported financial results.
Commitments and Contingencies
The Company reports and accounts for its commitments and contingencies in accordance with ASC 440 – Commitments and ASC 450 – Contingencies. We recognize a loss on a contingency when it is probable a loss will incur and that the amount of the loss can be reasonably estimated. As of April 30, 2020, and April 30, 2019, the Company recognized a loss on contingencies of zero and $0, respectively.
Stock Options
In September 2016, we adopted a stock option plan. We account for stock options in accordance with ASC 718 – Compensation – Stock Compensation for employees. The company incorporates ASC Subtopic 505-50, Equity – Equity Based Payments to Non-Employees for issuance of stock options to non-employees.
Recent Accounting Pronouncements
The Company evaluated all recent accounting pronouncements issued and determined that the adoption of these pronouncements would not have a material effect on the financial position, results of operations, or cash flows of the Company.
On December 15, 2016, the following two ASU’s became effective, ASU 2015-11, Simplifying the Measurement of Inventory issued July 2015 and ASU 2014-09, Revenue From Contracts With Customers, issued May 2014, and must be utilized in fiscal years beginning after the effective date. The company has adopted and implemented the standards as part of its 2017 fiscal year. The early implementation had no effect on the financial performance of the Company. The Company reports its inventory by segments.
In April 2014, the FASB issued ASU 2014-08, Reporting Discontinued Operations and Disclosures of Components of an Entity, which updates the definition of discontinued operations. Going forward, only those disposals of components of an entity that represent a strategic shift that has (or will have) a major effect on an entity's operations and financial results will be reported as discontinued operations in the financial statements. Previously, a component of an entity that is a reportable segment, an operating segment, a reporting unit, a subsidiary, or an asset group was eligible for discontinued operations presentation. Additionally, the condition that the entity not have any significant continuing involvement in the operations of the component after the disposal transaction has been removed. The effective date for the revised standard is for applicable transactions that occur within annual periods beginning on or after December 15, 2014. We do not expect the guidance to have a material impact on the Company.
In June 2014, the FASB issued ASU No. 2014-10, which eliminated certain financial reporting requirements of companies previously identified as “Development Stage Entities” (Topic 915). The amendments in this ASU simplify accounting guidance by removing all incremental financial reporting requirements for development stage entities. The amendments also reduce data maintenance and, for those entities subject to audit, audit costs by eliminating the requirement for development stage entities to present inception-to-date information in the statements of income, cash flows, and shareholder equity. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). Upon adoption, entities will no longer present or disclose any information required by Topic 915. The Company has adopted this standard and will not report inception-to-date information.
On May 28, 2014, the FASB issued ASU No. 2015-08 a standard on recognition of revenue from contracts with customers (Topic 606). An issue discussed relates to when another party, along with the entity, is involved in providing a good or a service to a customer. In those circumstances, Topic 606 requires the entity to determine whether the nature of its promise is to provide that good or service to the customer (that is, the entity is a principal) or to arrange for the good or service to be provided to the customer by the other party (that is, the entity is an agent). This determination is based upon whether the entity controls the good or the service before it is transferred to the customer. Topic 606 includes indicators to assist in this evaluation. The Company evaluated all its contracts to determine if the Company was a principal or agent. The Company has determined it was the principal in all its contracts.
In March 2016, the FASB issued ASU No. 2015-03 implementing the effective dates of Intangible – Goodwill and Other (Topic 350), Business Combinations (Topic 805), Consolidation (Topic 810) and Derivatives and Hedging (Topic 815) immediately. The Company has reviewed the topics and in compliance. The effects of the immediate implementation of these topics have had no effect on the financial statements of the Company.
In March 2016, the FASB issued ASU No. 2015-09, Compensation-Stock Compensation (Topic 718): “Improvements to Employee Share-Based Payment Accounting.” This ASU makes targeted amendments to the accounting for employee share-based payments. This guidance is to be applied using various transition methods such as full retrospective, modified retrospective, and prospective based on the criteria for the specific amendments as outlined in the guidance. The guidance is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted, as long as all of the amendments are adopted in the same period. The Company is currently evaluating the provisions of this guidance and assessing its impact on the Company’s financial statements and disclosures.
In August 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-15, “Presentation of Financial Statements—Going Concern: Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” ASU 2014-15, which is effective for annual reporting periods ending after December 15, 2015, extends the responsibility for performing the going-concern assessment to management and contains guidance on how to perform a going-concern assessment and when going-concern disclosures would be required under GAAP. We do not anticipate that the adoption of ASU 2014-15 will have a material impact on our consolidated financial condition or results from operations. Management’s evaluations regarding the events and conditions that raise substantial doubt regarding our ability to continue as a going concern as discussed in the notes to our consolidated financial statements included elsewhere.
We have implemented all other new accounting pronouncements that are in effect and that may impact our financial statements and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our consolidated financial position or results of operations.
Note 3. Going Concern
The Company's financial statements are prepared using generally accepted accounting principles, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. Because the business is new and has a limited history, no certainty of continuation can be stated. The accompanying financial statements for the years ended April 30, 2020 and 2019 have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.
The Company has negative cash flow and there are no assurances the Company will generate a profit or obtain positive cash flow. The Company has a nominal working capital deficit, which raise substantial doubt about its ability to continue as a going concern.
Management is taking steps to raise additional funds to address its operating and financial cash requirements to continue operations in the next twelve months. Management has devoted a significant amount of time in the raising of capital from additional debt and equity financing. However, the Company’s ability to continue as a going concern is dependent upon raising additional funds through debt and equity financing and generating revenue. There are no assurances the Company will receive the necessary funding or generate revenue necessary to fund operations. The financial statements contain no adjustments for the outcome of this uncertainty.
Note 4. Inventory and Work in Progress
The early implementation of ASU 2015-11, Simplifying the Measurement of Inventory had no effect on the financial performance of the Company. The Company reports its inventory by segments. The inventory levels for the segments for previous years are based upon best estimates of management and are provided for quality review measures only. The inventory and work in progress was eliminated as part of the discontinued operations.
Note 5: Accounts Receivable
The Company’s currently has no accounts receivable.
The accounts receivable for 2019 were eliminated as part of the discontinued operations.
Accounts Receivable
|
|
|
For the year ending April 30,
|
|
|
|
2020
|
|
|
2019
|
|
A/R from credit card reserve
|
|
$
|
-
|
|
|
$
|
27,462
|
|
A/R from direct customers
|
|
|
-
|
|
|
|
1,633,324
|
|
Subscription receivables
|
|
|
-
|
|
|
|
-
|
|
Allowance for bad debt
|
|
|
-
|
|
|
|
(1,395,605
|
)
|
Allowance for discontinued operations
|
|
|
-
|
|
|
|
(260,789
|
)
|
Total Accounts Receivable
|
|
$
|
-
|
|
|
$
|
4,392
|
|
Note 6. Property, Plant and Equipment
The following is a detail of equipment at April 30, 2020 and April 30, 2019:
Property, Plant, and Equipment
|
|
|
As of
|
|
|
As of
|
|
|
|
April 30, 2020
|
|
|
April 30, 2019
|
|
Office furniture
|
|
$
|
29,090
|
|
|
$
|
29,090
|
|
Rollies machine
|
|
|
5,066
|
|
|
|
5,066
|
|
Computer equipment
|
|
|
1,723
|
|
|
|
1,544
|
|
420 Cloud
|
|
|
3,129,412
|
|
|
|
3,129,412
|
|
Farm equipment
|
|
|
30,765
|
|
|
|
30,765
|
|
Warehouse equipment
|
|
|
193,388
|
|
|
|
67,471
|
|
Plant Development
|
|
|
21,605
|
|
|
|
-
|
|
Land
|
|
|
292,500
|
|
|
|
292,500
|
|
Total acquisition cost
|
|
$
|
3,703,549
|
|
|
$
|
3,555,848
|
|
Accumulated depreciation
|
|
|
894,707
|
|
|
|
835,986
|
|
Write-down
|
|
|
43,128
|
|
|
|
43,128
|
|
Sell of assets
|
|
|
314,105
|
|
|
|
-
|
|
Discontinued operations
|
|
|
2,451,609
|
|
|
|
2,676,480
|
|
Total property, plant, and equipment
|
|
$
|
-
|
|
|
$
|
254
|
|
Note 7. Cost Basis Investments
The Company has invested $1,300,065 through April 30, 2020 through various nonmonetary transactions. The Company has elected to impair a portion of its investments (see Note 9). A breakdown of these investments includes:
Cost Basis Investments
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
As of
|
|
|
|
April 30,
2020
|
|
|
April 30,
2019
|
|
Stony Hill Corp
|
|
$
|
700,000
|
|
|
$
|
700,000
|
|
Omni Health, Inc
|
|
|
152,023
|
|
|
|
152,023
|
|
New York Hemp Pilot Program
|
|
|
50,000
|
|
|
|
50,000
|
|
California City Cannabis Licenses
|
|
|
-
|
|
|
|
225,585
|
|
Investment in BRRX management
|
|
|
200,778
|
|
|
|
-
|
|
Agri-Contractors, LLC
|
|
|
160008
|
|
|
|
160,008
|
|
Redfern BioSystems, Inc.
|
|
|
9,949
|
|
|
|
9,949
|
|
Total acquisition cost
|
|
$
|
1,272,758
|
|
|
$
|
1,297,565
|
|
Impairment
|
|
|
(999,813
|
)
|
|
|
(386,031
|
)
|
|
|
$
|
272,945
|
|
|
$
|
911,534
|
|
Note 8. Intangible Assets:
The intangible assets consist of:
Intangible Assets
|
|
|
|
|
|
|
As of
|
|
|
As of
|
|
|
|
April 30,
2020
|
|
|
April 30,
2019
|
|
Domains
|
|
$
|
365,847
|
|
|
$
|
365,847
|
|
Trademarks
|
|
|
455,860
|
|
|
|
455,860
|
|
Website
|
|
|
30,491
|
|
|
|
30,491
|
|
Cannabis License
|
|
|
228,085
|
|
|
|
-
|
|
VitaCBD
|
|
|
200,000
|
|
|
|
200,000
|
|
Total acquisition cost
|
|
$
|
1,280,283
|
|
|
$
|
1,052,198
|
|
Less: Amortization
|
|
|
(752,193
|
)
|
|
|
(486,447
|
)
|
Adjustment for sale of asset
|
|
|
(72,880
|
)
|
|
|
(72,880
|
)
|
Write-off
|
|
|
(55,173
|
)
|
|
|
(5,975
|
)
|
Current Intangible Assets
|
|
$
|
400,037
|
|
|
$
|
486,896
|
|
Amortization expense on intangible assets was $265,749 and $263,197 for the years ended April 30, 2020 and 2019, respectively. The weighted average remaining useful life on intangible assets at April 30, 2020 is approximately 24 months.
The table below represents the estimated amortization of intangible assets for each of the next five years.
Year
|
|
Amortization
|
|
2021
|
|
$
|
171,952
|
|
2022
|
|
-0-
|
|
2023
|
|
-0-
|
|
2024
|
|
-0-
|
|
2025
|
|
-0-
|
|
Total
|
|
$
|
171,952
|
|
Note 9. Impairment Analysis
The following chart is a summary of the impairment analysis conducted in 2020 and the recommended impairment per asset. When a fair value was easily obtainable through third party independent resources it was utilized in calculating impairment. In addition to the fair value method, the company conducted an analysis utilizing the value in use method. We utilized gross revenue, EBIDTA, free cash flow, discount rate and factors and present value of free cash flow for a five-year period to determine current value of assets. Based upon the analysis the following chart shows the impairments that were recognized.
Name of Individual Assets
|
|
Stony Hill Stock
|
|
CARRYING AMOUNT
|
|
|
676,000
|
|
Assets sold during year
|
|
|
106,860
|
|
Current value
|
|
|
62,718
|
|
RECOVERABLE AMOUNT
|
|
|
62,718
|
|
Impairment losses recognized
|
|
|
(506,422
|
)
|
The following chart is a summary of the impairment analysis conducted in 2019 and the recommended impairment per asset. When a fair value was easily obtainable through third party independent resources it was utilized in calculating impairment. In addition to the fair value method, the company conducted an analysis utilizing the value in use method. We utilized gross revenue, EBIDTA, free cash flow, discount rate and factors and present value of free cash flow for a five-year period to determine current value of assets. Based upon the analysis the following chart shows the impairments that were recognized.
Name of Individual Assets
|
|
Omni Stock
|
|
|
Stony Hill Stock
|
|
|
Agri-Contractors
|
|
|
NY Hemp License
|
|
|
CA Hemp License
|
|
|
OBITX
|
|
CARRYING AMOUNT
|
|
|
152,023
|
|
|
|
700,000
|
|
|
|
160,008
|
|
|
|
50,000
|
|
|
|
225,585
|
|
|
|
2,879,273
|
|
Fair value less costs to sell
|
|
|
-
|
|
|
|
676,000
|
|
|
|
-
|
|
|
|
-
|
|
|
XCEEDS
|
|
|
|
2,799,159
|
|
Value in use
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
RECOVERABLE AMOUNT
|
|
|
-
|
|
|
|
676,000
|
|
|
|
-
|
|
|
|
-
|
|
|
XCEEDS
|
|
|
|
2,799,159
|
|
Impairment losses recognized
|
|
|
(152,023
|
)
|
|
|
(24,000
|
)
|
|
|
(160,008
|
)
|
|
|
(50,000
|
)
|
|
|
-
|
|
|
|
(80,114
|
)
|
Note 10: Liabilities
Notes Payable
The notes payable of $375,000 is owed to Apex Management under settlement agreement. The Company currently pays $20,000 per month.
In addition to these amounts, we owe Paul Rosenberg (see Related Party) $110,193 as due to related party. There are no current agreements in place for these payments made by Paul Rosenberg on behalf of the Company. The Company treats these as notes payable to a related party.
Accounts Payable
The following table represents the outstanding payables and accrued expenses:
Accounts Payable and Accrued Expenses
|
|
|
As of April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Payroll liabilities
|
|
$
|
-
|
|
|
$
|
48,516
|
|
A/P to related parties
|
|
|
-
|
|
|
|
441,125
|
|
A/P for corporate
|
|
|
-
|
|
|
|
7,516
|
|
A/P for construction
|
|
|
53,531
|
|
|
|
74,251
|
|
A/P for retail sales
|
|
|
-
|
|
|
|
114,793
|
|
A/P for technologies
|
|
|
-
|
|
|
|
14,633
|
|
A/P for agriculture
|
|
|
119,787
|
|
|
|
129,787
|
|
Total Accounts Receivable
|
|
$
|
173,317
|
|
|
$
|
830,621
|
|
Note 11: Consolidated Statements of Operations Notes
Professional Fees
The Company’s professional fees consists of legal fees, accounting fees, securities fees, and other licensed professional fees. The legal fees include general corporate counsel fees, legal expenses associated with various lawsuits, and the preparation of SEC filings. Following is a breakdown of the professional fees for the periods ending April 30, 2020 and April 30, 2019:
Professional Fees
|
|
|
|
|
|
|
For the year ending April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Legal fees associated with litigation
|
|
$
|
-
|
|
|
$
|
256,803
|
|
Corporate legal fees
|
|
|
38,327
|
|
|
|
69,965
|
|
Accounting fees
|
|
|
19,500
|
|
|
|
52,967
|
|
Securities fees
|
|
|
5,375
|
|
|
|
27,421
|
|
Other licensed professional fees
|
|
|
-
|
|
|
|
6,675
|
|
Adjustment for discontinued ops
|
|
|
(21,929
|
)
|
|
|
-
|
|
Total Professional fees
|
|
$
|
41,273
|
|
|
$
|
413,831
|
|
Selling, General, and Administration
The Company’s selling, general, and administration expenses were $401,739 and $536,735 for the periods ending April 30, 2020 and April 30, 2019, respectively. The following chart is a breakdown of those expenses:
Selling, General, and Administration
|
|
|
|
|
|
|
For the year ending April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Auto Expenses
|
|
$
|
9,403
|
|
|
$
|
12,729
|
|
Bank service charges
|
|
|
4,541
|
|
|
|
6,122
|
|
Business License
|
|
|
3,963
|
|
|
|
159
|
|
Payroll
|
|
|
291,198
|
|
|
|
331,090
|
|
Travel
|
|
|
12,493
|
|
|
|
50,596
|
|
Office Supplies
|
|
|
37,766
|
|
|
|
57,728
|
|
Computer and Internet Expenses
|
|
|
11,018
|
|
|
|
17,517
|
|
Shipping and Postage
|
|
|
100
|
|
|
|
737
|
|
Rent
|
|
|
28,735
|
|
|
|
55,509
|
|
Research and Development
|
|
|
-
|
|
|
|
710
|
|
Utilities
|
|
|
2,615
|
|
|
|
3,838
|
|
Adjustment for discontinued ops
|
|
|
(390,375
|
)
|
|
|
-
|
|
|
|
$
|
11,457
|
|
|
$
|
536,735
|
|
Bad Debts
The Company has recorded bad debt in the amounts of $0 and $1,372,725 for the periods ending April 30, 2020 and April 30, 2019, respectively. The $1,372,725 of bad debt for the period ending April 30, 2019 consists of $1,254,500 of bad debt through OBITX, $113,833 with CBJ, and $4,392 of bad debt in BOTS.
Note 12: Discontinued Operations
In 2020 the Company elected to discontinue its operations in retail operations which included sales under VitaCig, MCig Internet, CBJ, and Vapolution. The retail discontinued operation loss for the year ending April 30, 2020 was $3,165,717.
In 2019 the Company elected to discontinue its operations in construction under GROW and agriculture under NYACRES. In addition, OBITX has discontinued its operations under altCUBE. The following chart shows the losses we have incurred as part of the discontinued operations.
In addition, we adjusted our assets and liabilities accordingly.
Discontinued Operations
|
|
mCig Internet
|
|
$
|
(60,400
|
)
|
Vapolution
|
|
|
(92,452
|
)
|
CBJ
|
|
|
(125,289
|
)
|
VitaCig
|
|
|
(296,374
|
)
|
Adjust assets/liabilities
|
|
|
(2,591,202
|
)
|
Total
|
|
$
|
(3,165,717
|
)
|
Note 13. Sale of Asset
On September 15, 2019 the Company sold the domain name www.cbd.biz to Redfern BioSystems, Inc., for $90,000. The following chart represents that sale transaction.
Sale of CBD.BIZ
|
|
Notes receivable
|
|
|
100,000
|
|
Income for financing
|
|
|
(10,000
|
)
|
Total sales price
|
|
$
|
90,000
|
|
Domain name acquisition cost
|
|
|
82,500
|
|
Accumulated amortization
|
|
|
(11,458
|
)
|
Total reductions from sales price
|
|
|
71,042
|
|
Gain on asset
|
|
$
|
18,958
|
|
The Company entered into a secured convertible promissory note with Redfern. The note is due on September 14, 2020. Should Redfern default the Company may convert the secured promissory note into 40 million common shares of Redfern representing approximately 75% of the business. Should the Company not elect to convert in the event of nonpayment by Redfern, the Company may take possession of the domain www.cbd.biz and its business operations. On September 18, 2019 the Company assigned the note to Paul Rosenberg and Michael Hawkins (see Related Party Transactions).
Note 14. Related Parties and Related Party Transactions
Related Parties
In addition to the subsidiaries of the Company, the following individuals/entities have been identified as related parties in accordance with the guidelines of ASC 850 – Related Party Disclosures:
Related Parties
|
Name/Entity
|
|
Position
|
|
Became
|
|
Ended
|
Paul Rosenberg
|
|
CEO/Director
|
|
January 1, 2012
|
|
Current
|
Michael Hawkins
|
|
CFO
|
|
April 8, 2016
|
|
August 30, 2019
|
OBITX, Inc.
|
|
Significant Shareholder
|
|
April 3, 2017
|
|
Current
|
Related Party Transactions
The Company entered a Line of Credit with Paul Rosenberg (see Subsequent Events) for up to $100,000 in funding on May 1, 2016. On May 1, 2017, the Company increased the amount of the Line of Credit and Convertible Promissory Note for up to $250,000 in funding by Paul Rosenberg to accurately record the day-to-day transactions of the Company and Paul Rosenberg. In February 2019 we increased the line of credit to $1,000,000. As of April 30, 2019, the Company owed Mr. Rosenberg $1,219,412, which included the amount of $120,000 earned, covered under his employment agreement which was not paid to Mr. Rosenberg. On August 1, 2019 the Company settled the account reducing the amount owed to Paul Rosenberg in the amount of $1,221,871. As payment of this amount was the transfer of the real estate property owned by CAAcres, Inc., in the amount of $314,105 and the transfer of ATM’s owned in the amount of $408,166, with the remainder of the amount due recognized as gain on sale of assets. Since the settlement, Paul Rosenberg has expended an additional $110,923 to third party vendors on behalf of MCIG. The Company has no agreement with Paul Rosenberg for these payments. The Company records the advances as payable to related party.
On September 1, 2016, the Company entered into an employment agreement with Michael Hawkins, the Chief Financial Officer and an employment agreement with Paul Rosenberg, the Chief Executive Officer of the Company (“employees”). Mr. Hawkins was the Interim Chief Financial Officer which agreement was scheduled to expire on September 6, 2016. Mr. Rosenberg has been the CEO since inception and served without an agreement. The terms of the Agreement are the same. The agreements call for $156,000 per year base salary with a three-year term. Only $3,000 per month guaranteed to be paid in cash, while the remainder ($10,000 per month) is booked as a note due, which may be converted into shares of the company at then current price per share. The initial year’s conversion option was accrued upon entering into the agreement. The employees earn annual bonuses based upon gross sales, net profits, and annual increases in sales and profits. The Company and employees may elect to convert a portion of this salary into equity of the company. In addition, each employee was issued a seven-year warrant to acquire four percent (4%) of the Company Stock at the market price as of September 1, 2016 with 25% vested immediately and 25% on each subsequent year anniversary of employment. On September 1, 2017 Mr. Hawkins agreement was modified to $10,000 per month and his options vested. The employment agreements expired on August 30, 2019. Mr. Hawkins elected not to extend the agreement and resigned as the Chief Financial Officer. Paul Rosenberg stopped receiving payments under his agreement effective October 31, 2019 and currently receives no compensation as CEO/CFO of the Company.
On August 2, 2018 Paul Rosenberg converted 8,000,000 Series A Preferred stock into 80,000,000 common shares of stock.
On August 15, 2018 Paul Rosenberg and Michael Hawkins became the majority owners of Tuero Capital, Inc., which subsequently changed its name to Redfern BioSystems, Inc. The Company converted its outstanding of $9,949 debt into equity and currently owns 1,902,375. Subsequently the company sold www.cbd.biz to Redfern BioSystems (see Note 15: Sale of Asset).
On August 1, 2018 the company’s Chief Financial Officer, Michael Hawkins, exercised a Warrant purchasing 5,416,551 shares of common stock at the price of $0.025, totaling $135,414. The purchase price was offset by the $135,414 owed to Mr. Hawkins under his employment agreement. The shares were issued to Epic Industry Corp, a private company owned 100% by Michael Hawkins.
On May 2, 2019 Paul Rosenberg converted 500,000 shares of Series A Preferred Stock into 5,000,000 common shares of stock.
On October 13, 2019 Paul Rosenberg retired 30,000,000 shares of common stock.
On October 13, 2019 the Company settled the account payable owed Paul Rosenberg and Michael Hawkins. In exchange for the elimination of $295,725 owed to Paul Rosenberg and $129,140 owed to Michael Hawkins, the Company provided $27,930 of assets owned by VitaCig, and assigned the $100,000 owed by Redfern to the Company to Paul Rosenberg and Michael Hawkins. The remaining balance of $296,935 was recorded as a gain on the sale of assets.
The Company entered a Line of Credit with OBITX, to provide up to $500,000 in funding on November 1, 2016. It was given at a 0% interest rate and is payable upon termination date with the option to convert the agreement into equity at a 15% discount to the then current market rate. The Line of Credit was increased to $1,000,000 on January 1, 2018 and expired January 1, 2020. As of April 30, 2020, and April 30, 2019, the amount outstanding on the Line of Credit owed to MCIG was $218,257 and $618,277, respectively. (For further information see Note 22 – Subsequent Events).
Note 15. Commitments and Contingencies
Rent expense for the year ended April 30, 2020 and 2019 was $28,735 and $55,509, respectively. The company currently rents office space through its registered agent in Puerto Rico on a month-by-month basis.
Note 16. Stockholders’ Equity
Common Stock
The Company was authorized to issue 2,000,000,000 common shares at a par value of $0.0001. As of April 30, 2020, the Company had issued and outstanding, 505,374,596 common shares. During 2020 we issued 20,250,00 shares of common stock and cancelled 30,000,000 shares of common stock for a net reduction of 9,750,000.
Preferred Stock
The Company has authorized 90,000,000 shares of preferred stock, of which it has designated 90,000,000 as Series A Preferred, at $0.0001 par value. The Company has 3,350,000 issued and outstanding as of April 30, 2020. Each share of the Preferred Stock has 10 votes on all matters presented to be voted by the holders of the Company’s common stock.
During 2020 APO Holdings elected to convert 1,000,000 shares of Series A Preferred stock into 10,000,000 shares of common stock.
Note 17. Income Taxes
The items accounting for the difference between income taxes computed at the federal statutory rate and the provision for income taxes were as follows:
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Statutory federal income tax rate
|
|
|
34.0
|
%
|
|
|
34.0
|
%
|
State income taxes, net of federal taxes
|
|
|
6.0
|
%
|
|
|
6.0
|
%
|
Non-deductible items
|
|
|
(1.0
|
)%
|
|
|
(1.0
|
)%
|
Valuation allowance
|
|
|
(39.0
|
)%
|
|
|
(39.0
|
)%
|
Effective income tax rate
|
|
|
0.0
|
%
|
|
|
0.0
|
%
|
The Company may not be able to utilize the net operating loss carry forwards for its U.S. income taxes in future periods should it experience a change in ownership as defined in Section 382 of the Internal Revenue Code (“IRC”). Under section 382, should the Company experience a more than 50% change in its ownership over a 3-year period, the Company would be limited based on a formula as defined in the IRC to the amount per year it could utilize in that year of the net operating loss carry forwards. Section 382 of the Internal Revenue Code (“IRC”) imposes limitations on the use of NOL’s and credits following changes in ownership as defined in the IRC. The limitation could reduce the amount of benefits that would be available to offset future taxable income each year, starting with the year of an ownership change. The Company has not completed the complex analysis required by the IRC to determine if an ownership change has occurred.
Income Tax Computation
|
|
|
2020
|
|
|
2019
|
|
|
|
Tax Asset
|
|
|
Tax Asset
|
|
Income (Loss) per Books
|
|
|
(3,883,988
|
)
|
|
|
(3,057,241
|
)
|
Sales of non-taxable assets
|
|
|
-
|
|
|
|
-
|
|
Deferred Expenses
|
|
|
-
|
|
|
|
-
|
|
Stock-based compensation
|
|
|
273,000
|
|
|
|
28,900
|
|
Stock received for sales
|
|
|
-
|
|
|
|
-
|
|
Amortization
|
|
|
172,199
|
|
|
|
-
|
|
NOL (Net Income)
|
|
|
3,438,789
|
|
|
|
3,028,341
|
|
Prior NOL
|
|
|
3,422,318
|
|
|
|
413,977
|
|
Current NOL
|
|
|
6,881,107
|
|
|
|
3,422,318
|
|
At April 30, 2020 and 2019, the Company had net operating loss carry forwards available to offset future taxable income of approximately $6,881,107 and $3,422,228, respectively. These carry forwards will begin to expire in the year ending December 31, 2026. Utilization of the net operating loss carry forwards may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended and similar state provisions.
The Company has not performed a change in ownership analysis since its inception in 2010 and, accordingly, some or all of its net operating loss carry forwards may not be available to offset future taxable income. Even if the loss carry forwards are available, they may be subject to substantial annual limitations resulting from past ownership changes, and ownership changes occurring after April 30, 2020, that could result in the expiration of the loss carry forwards before they are utilized.
The nature of the components of the deferred tax asset is entirely attributable to the Net operating loss carry-forwards incurred by the Company less any permanent differences that maybe used in future years to offset future tax liabilities. We believe that it is more likely than not that the benefit from certain NOL carryforwards will not be realized. In recognition of this risk, we have provided a valuation allowance to offset the deferred tax assets relating to these NOL carryforwards.
The Company periodically evaluates the likelihood of the realization of deferred tax assets and adjusts the carrying amount of the deferred tax assets by the valuation allowance to the extent the future realization of the deferred tax assets is not judged to be more likely than not. The Company considers many factors when assessing the likelihood of future realization of its deferred tax assets, including its recent cumulative earnings experience by taxing jurisdiction, expectations of future taxable income or loss, the carry-forward periods available to the Company for tax reporting purposes, and other relevant factors. At April 30, 2020 and 2019, deferred tax assets have been fully offset by a valuation allowance.
The Company files income tax returns in the U.S. federal jurisdiction, and with the State of California, Florida, New York, and Nevada. The Company is subject to U.S. federal and state income tax examinations by tax authorities for tax years 2014 through 2019 due to net operating losses that are being carried forward for tax purposes. The Company does not have any uncertain tax positions or unrecognized tax benefits at April 30, 2020 or 2019. The Company’s policy is to recognize interest and penalties related to income taxes as components of interest expense and other expense, respectively.
Note 18. Basic Loss per Share before Non-Controlling Interest
Basic Loss Per Share - The computation of basic and diluted loss per common share is based on the weighted average number of shares outstanding during each period.
Basic Income (Loss) Per Common Share
|
|
|
For the period ended April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Net income from continuing operation (loss) before non-controlling interest
|
|
|
(718,386
|
)
|
|
|
(3,655,702
|
)
|
Net income (loss) before non-controlling interest
|
|
|
(3,883,988
|
)
|
|
|
(4,134,947
|
)
|
Net income (loss) from non-controlling interest
|
|
|
-
|
|
|
|
1,077,706
|
|
Net income (loss)
|
|
|
(3,883,988
|
)
|
|
|
(3,057,241
|
)
|
Basic income (loss) per common share from continuing operation
|
|
|
(0.0014
|
)
|
|
|
(0.0074
|
)
|
Basic income (loss) per common share from non-controlling interest
|
|
|
0.0000
|
|
|
|
0.0022
|
|
Basic income (loss) per share
|
|
|
(0.0076
|
)
|
|
|
(0.0062
|
)
|
Basic weighted average number of shares outstanding
|
|
|
505,071,171
|
|
|
|
493,439,072
|
|
The computation of basic loss per common share is based on the weighted average number of shares outstanding during the year.
Note 19. Stock Option Plan
Under its Year 2016 Stock Option Plan (the “Plan”), the Company grants stock options for a fixed number of shares to employees and directors with an exercise price equal to the fair market value of the shares at the date of grant.
Options granted under the Plan are exercisable at the exercise price of grant and, subject to termination of employment, expire three years from the date of issue, are not transferable other than on death, and vest in monthly installments commencing at various times from the date of grant. As of April 30, 2020, the Company recorded compensation cost of $0 within operating expenses related to stock options granted in 2020.
The Company issued no options during fiscal year 2020. The weighted average fair value at date of grant for options granted during fiscal 2019 is $0.1362 per option. The fair value of each option at date of grant utilized the closing price of the stock on the date of issue.
A summary of the Company’s stock option plan as of April 30, 2020 is presented below:
Stock Option Summary
|
|
|
Shares
|
|
|
Weighted Average Exercise Price
|
|
Options outstanding at May 1, 2018
|
|
|
12,076,830
|
|
|
$
|
0.0485
|
|
Granted in FY 2019
|
|
|
-
|
|
|
|
-
|
|
Forfeited in FY 2019
|
|
|
69,419
|
|
|
|
0.1840
|
|
Exercised in FY 2019
|
|
|
596,249
|
|
|
|
0.0340
|
|
Options outstanding at April 30, 2019
|
|
|
11,550,000
|
|
|
|
0.0485
|
|
|
|
|
|
|
|
|
|
|
Granted in FY 2019
|
|
|
-
|
|
|
|
-
|
|
Forfeited in FY 2019
|
|
|
-
|
|
|
|
-
|
|
Exercised in FY 2019
|
|
|
-
|
|
|
|
-
|
|
Options outstanding at April 30, 2020
|
|
|
11,550,000
|
|
|
$
|
0.0485
|
|
There are currently 14,400,000 unissued options under the 2016 Stock Option Plan.
The following table summarizes information for stock options outstanding at April 30, 2020:
|
|
Options Outstanding
|
|
Options Exercisable
|
|
|
|
|
|
Weighted-
|
|
Weighted-
|
|
|
|
Weighted-
|
|
Range of
|
|
Number
|
|
Average
|
|
Average
|
|
Number
|
|
Average
|
|
Exercise
|
|
Outstanding
|
|
Remaining
|
|
Exercise
|
|
Exercisable
|
|
Exercise
|
|
Prices
|
|
@ 4/30/20
|
|
in years
|
|
Price
|
|
@ 4/30/19
|
|
Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$0.034 - $0.244
|
|
|
11,550,000
|
|
|
-
|
|
$
|
0.0937
|
|
|
11,550,000
|
|
$
|
0.0937
|
|
Note 20. Warrants
A total of 43,332,412 warrants were issued on September 1, 2016 to various individuals/entities. These warrants were issued as a condition of employment agreements with the CEO and CFO. A total of 10,833,103 shares vests immediately with 10,833,103 vesting on the anniversary date for three years. The conversion price of the warrants is at $0.025.
On January 31, 2017, the company granted Mr. Rosenberg and Mr. Hawkins a five-year warrant to purchase 250,000 shares each of common stock at $0.75 per share.
On September 1, 2017 the remaining warrants issued to Michael W. Hawkins were vested in exchange for his reduction in salary.
A summary of warrant activity for period ended April 30, 2020 is as follows:
Stock Warrant Summary
|
|
|
Shares
|
|
|
Weighted Average Exercise Price
|
|
Warrants outstanding at May 1, 2018
|
|
|
26,582,579
|
|
|
$
|
0.0250
|
|
Granted in FY 2019
|
|
|
-
|
|
|
|
-
|
|
Exercised in FY 2019
|
|
|
5,416,551
|
|
|
|
0.0250
|
|
Warrants outstanding at April 30, 2019
|
|
|
21,166,208
|
|
|
|
0.2060
|
|
|
|
|
|
|
|
|
|
|
Granted in FY 2020
|
|
|
-
|
|
|
|
-
|
|
Exercised in FY 20120
|
|
|
-
|
|
|
|
-
|
|
Options outstanding at April 30, 2020
|
|
|
21,166,208
|
|
|
$
|
0.2060
|
|
Note 21. Explanation of Restatement of Balance Sheet for January 31, 2019
The Company is filing a restatement of its year ending Balance Sheet for the period ending April 30, 2019, which was filed with the Securities and Exchange Commission (“SEC”) on November 19, 2019 (the “Original Report”) and subsequently with each quarterly report filed with the SEC. The financial statements contained in our Annual Report on Form 10-K for the period ended April 30, 2019 require restatement in order to account for the discontinued operations of the Company in order for a comparative review for subsequent year endings. The changes in our consolidated Balance Sheet are summarized, below.
|
|
For the year ending
|
|
|
|
January 31, 2019
|
|
|
|
Original
|
|
|
Change
|
|
|
Restated
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Current Assets
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
281,832
|
|
|
|
(267,514
|
)
|
|
|
14,318
|
|
Accounts receivable, net
|
|
|
265,181
|
|
|
|
(260,789
|
)
|
|
|
4,392
|
|
Inventory
|
|
|
818,359
|
|
|
|
(818,359
|
)
|
|
|
-
|
|
Work in progress
|
|
|
21,605
|
|
|
|
(21,605
|
)
|
|
|
-
|
|
Notes and other receivable
|
|
|
130,193
|
|
|
|
(30,193
|
)
|
|
|
100,000
|
|
Prepaid expenses
|
|
|
13,940
|
|
|
|
(3,940
|
)
|
|
|
10,000
|
|
Discontinued operations assets
|
|
|
-
|
|
|
|
4,242,032
|
|
|
|
4,242,032
|
|
Total current assets
|
|
|
1,531,110
|
|
|
|
2,839,632
|
|
|
|
4,370,742
|
|
Property, plant and equipment, net
|
|
|
2,676,734
|
|
|
|
(2,676,480
|
)
|
|
|
254
|
|
Cost basis investment
|
|
|
911,534
|
|
|
|
(9,949
|
)
|
|
|
901,585
|
|
Intangible assets, net
|
|
|
486,896
|
|
|
|
(153,203
|
)
|
|
|
333,693
|
|
Total assets
|
|
|
5,606,274
|
|
|
|
-
|
|
|
|
5,606,274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities & stock equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
|
830,621
|
|
|
|
(316,938
|
)
|
|
|
513,683
|
|
Due to shareholder
|
|
|
1,219,412
|
|
|
|
-
|
|
|
|
1,219,412
|
|
Other current liabilities
|
|
|
391,885
|
|
|
|
(82,787
|
)
|
|
|
309,098
|
|
Deferred Revenue
|
|
|
20,977
|
|
|
|
(20,977
|
)
|
|
|
-
|
|
Discontinued liabilities
|
|
|
-
|
|
|
|
420,702
|
|
|
|
420,702
|
|
Total current liabilities
|
|
|
2,462,895
|
|
|
|
-
|
|
|
|
2,462,895
|
|
Long term liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes payable
|
|
|
275,000
|
|
|
|
-
|
|
|
|
275,000
|
|
Total long term liabilities
|
|
|
275,000
|
|
|
|
-
|
|
|
|
275,000
|
|
Total Liabilities
|
|
|
2,737,895
|
|
|
|
-
|
|
|
|
2,737,895
|
|
Stockholders' equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, $0.0001 par value
|
|
|
435
|
|
|
|
-
|
|
|
|
435
|
|
Common stock, $0.0001 par value, voting
|
|
|
51,512
|
|
|
|
-
|
|
|
|
51,512
|
|
Treasury stock
|
|
|
(680,330
|
)
|
|
|
-
|
|
|
|
(680,330
|
)
|
Additional paid in capital
|
|
|
13,968,212
|
|
|
|
-
|
|
|
|
13,968,212
|
|
Accumulated deficit
|
|
|
(9,265,671
|
)
|
|
|
-
|
|
|
|
(9,265,671
|
)
|
Total stockholders' equity
|
|
|
4,074,158
|
|
|
|
-
|
|
|
|
4,074,158
|
|
Non-controlling interest
|
|
|
(1,205,779
|
)
|
|
|
-
|
|
|
|
(1,205,779
|
)
|
Total equity
|
|
|
2,868,379
|
|
|
|
-
|
|
|
|
2,868,379
|
|
Total liabilities and stockholders' equity
|
|
|
5,606,274
|
|
|
|
-
|
|
|
|
5,606,274
|
|
Note 22. Subsequent Events
On May 15, 2020 the Company issued 50,000,000 shares of common stock to Overwatch Partners, Inc., as part of payment for services provided by Michael Hawkins during the transition between his resignation as the CFO and the acquisition of BOTS.
On May 15, 2020 issued 80,000,000 shares of common stock as stock-based compensation to Paul Rosenberg.
On May 15, 2020 the Company issued 10,000,000 each to the Law Offices of Carl G Hawkins and the Law Offices of Thomas G Amon for legal services.
On May 17, 2020 the Company acquired the assets of First Bitcoin Capital, Inc. The Company issued 100,000,000 common shares of stock and 30,000,000 Series A Preferred shares of stock. The Company is obligated to issue an additional 60,000,000 shares of Series A Preferred stock at the rate of 10,000,000 per quarter under certain conditions.
On June 3, 2020 the Company entered into a settlement agreement with BRRX terminating the joint venture.
In October 2020 we converted 5,000,000 of OBITX, Inc., common shares owned by us into 500,000 shares of Series B Preferred stock. The conversion was according to the terms of the Series B Preferred stock and as such there was no gain or loss on the transaction. BOTS may not convert the Series B Preferred shares into common shares until 24 months have expired from the transaction.
On September 30, 2020 we received 27,000,000 BIT tokens from OBITX as payment of the outstanding note receivable of $218,257.
In October 2020 Redfern BioSystems, Inc., was shutdown. The few assets held by Redfern were used to settled debts owed to creditors. We received no compensation for our shares of Redfern BioSystems, Inc., and as such wrote off the asset.
On November 23, 2020 the Company issued 1,000,000 shares of common stock to George L Richard III for legal services provided to the Company.
On November 23, 2020 the Company issued 1,000,000 shares of common stock to OTC Investments, LLC, for consulting services as a condition for entering into an agreement.
On November 24, 2020 the Company issued 1,000,000 shares of common stock to Moneta Equitiess, LLC, for consulting services as a condition for entering into an agreement.
On November 24, 2020 the Company issued 1,000,000 shares of common stock to Cyber Security Group, LLC, for consulting services as a condition for entering into an agreement.